genomic testing in identifying patients with dcis likely to respond to radiotherapy
Published 2 years ago • 196 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
1:43
using dcisionrt to assess benefit of radiotherapy in patients with dcis following lumpectomy
-
6:23
stratifying patients with breast cancer by a 7-gene assay for endocrine therapy
-
5:26
improving risk prediction and decision making in dcis patients
-
0:34
unanswered questions in dcis progression
-
0:57
predictive biomarkers of recurrence may not be useful for de-escalating treatment in dcis
-
14:37
genomic testing in breast cancer: what you must know
-
1:17
future advances in dcis: de-escalation of hormonal therapy
-
0:38
clinical implications for recurrent nonclonal primary dcis
-
1:52
remaining questions in ductal carcinoma in situ
-
1:12
impact of genomic testing on treatment decision-making in breast cancer
-
3:38
how genomic testing helped this appendiceal cancer patient
-
1:03
genomic testing for breast cancer patients
-
21:53
dcis recurrence and radiation
-
3:38
an evaluation of the impact of dcis diagnosis on the patients' wellbeing
-
14:29
multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ
-
2:11
a genome-based model for adjusting radiotherapy dose
-
1:09
when should women with dcis get radiation?
-
1:37
genetic and genomic test difference for breast cancer patients
-
16:06
extensive dcis and microcalcifications in patients with breast cancer reaching pcr after nac